
Rekindletech Pharmaceuticals Private Limited
Pharmaceutical trading company offering a variety of products including tablets, capsules, injections, and more.
Pharmaceutical trading company offering a variety of products including tablets, capsules, injections, and more.
Rekindletech Pharmaceuticals Private Limited (RPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 July 2020 (Four years and seven months 20 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.50 M.
Rajesh Upadhyay, Siddharth Singh, and Kuldeep Upadhyay serve as directors at the Company.
Gandhi Nagar, Gujarat, India
+91-XXXXXXXXXX
-
U24297GJ2020PTC114639
114639
Private Limited Indian Non-Government Company
15 Jul 2020
30 Sep 2024
31 Mar 2024
Unlisted
Roc Ahmedabad
Rekindletech Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Reliever Gel, Nutraceuticals & Dietary Supplements, Fitness Supplements, Common Disease Medicines, Pharmaceutical Capsules.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kuldeep Upadhyay ![]() | Director | 15-Jul-2020 | Current |
Rajesh Upadhyay ![]() | Director | 16-May-2024 | Current |
Siddharth Singh ![]() | Director | 27-Apr-2022 | Current |
Rekindletech Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2021, Rekindletech Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Siddharth Singh is a mutual person
₹4.50 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
17 Oct 2022 | Others | ₹4.50 M | Open |
Rekindletech Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rekindletech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rekindletech Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rekindletech Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Rajesh Upadhyay was appointed as a Director was appointed as a Director on 16 May 2024 & has been associated with this company since 9 months 19 days .
Rekindletech Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
A charge with Others amounted to Rs. 4.50 M with Charge ID 100657632 was registered on 17 Oct 2022.
Siddharth Singh was appointed as a Director was appointed as a Director on 27 Apr 2022 & has been associated with this company since 2 years 10 months .
Kuldeep Upadhyay was appointed as a Director was appointed as a Director on 15 Jul 2020 & has been associated with this company since 4 years 7 months .
Rekindletech Pharmaceuticals Private Limited was incorporated on 15 Jul 2020.
The authorized share capital of Rekindletech Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 3 directors are associated with Rekindletech Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rekindletech Pharmaceuticals Private Limited is C-304 Devnandan Altezza Opp Heights, Village Chandkeda India, Ahmedabad, Gujarat, 382424.
The corporate identification number (CIN) of Rekindletech Pharmaceuticals Private Limited is U24297GJ2020PTC114639 and the company number is 114639 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2021, The total open charges for Rekindletech Pharmaceuticals Private Limited amount to ₹ 4.50 M.
The most recent Balance Sheet for Rekindletech Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
S
JS